45 results
Page 2 of 3
8-K
km847xv
30 Jun 20
Departure of Directors or Certain Officers
5:01pm
8-K
1kwf7rel7
11 Jun 20
Departure of Directors or Certain Officers
5:00pm
8-K
EX-99.2
lr1wri63gdy0f
29 May 20
Arvinas Releases Updated Dose Escalation Data from Clinical Trial of PROTAC® Protein Degrader
7:06am
8-K
EX-99.1
xb3dy
29 May 20
Arvinas Releases Updated Dose Escalation Data from Clinical Trial of PROTAC® Protein Degrader
7:06am
8-K
6e89a7wup75 fbnp
21 Nov 19
Departure of Directors or Certain Officers
4:10pm
424B5
mpcup6yuuibk8p qmghz
7 Nov 19
Prospectus supplement for primary offering
4:05pm
424B5
fd4sq6sp7j58u650pd
6 Nov 19
Prospectus supplement for primary offering
5:31pm
8-K
EX-99.2
6en754135u wpekw
23 Oct 19
Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTAC® Targeted Protein Degraders
6:39am
8-K
pfsncji bnyp47in7i
25 Jul 19
Departure of Directors or Certain Officers
4:50pm
DEF 14A
3kk 0bkszlthyh
12 Apr 19
Definitive proxy
5:02pm
10-K
gxkkhnkdhr3ul6ks2t6e
26 Mar 19
Annual report
4:31pm
8-K
EX-3.1
nq5uib51de
1 Oct 18
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
EX-3.2
v5y05ctrc4
1 Oct 18
Amendments to Articles of Incorporation or Bylaws
4:02pm
DRS/A
EX-3.1
m1ci tcr4
2 Aug 18
Draft registration statement (amended)
12:00am
DRS/A
11fg4jfeycms
2 Aug 18
Draft registration statement (amended)
12:00am